This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: University of Ghent. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
Title: Eric Cox: Innovator in Mucosal Membrane Receptor Research
Introduction
Eric Cox is a notable inventor based in Merelbeke, Belgium. He has made significant contributions to the field of immunology, particularly through his research on mucosal membrane receptors. With a total of 3 patents, his work has the potential to impact therapeutic approaches for bacterial diarrhea and immune response modulation.
Latest Patents
One of Eric Cox's latest patents is titled "Mucosal membrane receptor and uses thereof." This invention identifies aminopeptidase N (APN) as the receptor for F4 fimbriae of enterotoxigenic E. coli (ETEC). The research demonstrates that oral administration of F4 fimbriae can induce a protective intestinal mucosal immune response against subsequent challenges with F4 ETEC. The invention also highlights the clathrin-mediated internalization of F4 fimbriae, providing a basis for developing carriers that deliver antigens or therapeutics to the intestinal submucosa or mucosa-associated lymphoid tissue. These carriers can be utilized in methods to induce antigen-specific immune responses and treat bacterial diarrhea.
Career Highlights
Eric Cox has worked at prestigious institutions such as Universiteit Gent and VIB (Flanders Institute for Biotechnology). His research has focused on the intersection of immunology and microbiology, leading to innovative solutions in health care.
Collaborations
Throughout his career, Eric has collaborated with notable colleagues, including Kristien Rasschaert and Bruno Goddeeris. These partnerships have enriched his research and contributed to the advancement of knowledge in his field.
Conclusion
Eric Cox's innovative work in mucosal membrane receptor research exemplifies the impact of scientific inquiry on health solutions. His patents and collaborations reflect a commitment to advancing immunological therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
